ConvaTec Group PLC (LON:CTEC) insider Frank Schulkes bought 50,000 shares of the company’s stock in a transaction that occurred on Tuesday, October 31st. The stock was purchased at an average cost of GBX 196 ($2.59) per share, for a total transaction of £98,000 ($129,321.72).

ILLEGAL ACTIVITY WARNING: This article was originally published by Watch List News and is the property of of Watch List News. If you are viewing this article on another publication, it was illegally stolen and republished in violation of U.S. and international trademark and copyright legislation. The original version of this article can be accessed at https://www.watchlistnews.com/convatec-group-plc-ctec-insider-frank-schulkes-buys-50000-shares/1671908.html.

A number of brokerages recently issued reports on CTEC. Peel Hunt lowered ConvaTec Group PLC to a “hold” rating and dropped their target price for the company from GBX 390 ($5.15) to GBX 250 ($3.30) in a research report on Tuesday, October 17th. Numis Securities Ltd reissued a “reduce” rating and issued a GBX 260 ($3.43) target price on shares of ConvaTec Group PLC in a research report on Thursday, August 3rd. J P Morgan Chase & Co dropped their target price on ConvaTec Group PLC from GBX 318 ($4.20) to GBX 303 ($4.00) and set an “overweight” rating on the stock in a research report on Friday, August 4th. Citigroup Inc. reissued a “neutral” rating and issued a GBX 290 ($3.83) target price on shares of ConvaTec Group PLC in a research report on Wednesday, October 11th. Finally, Deutsche Bank AG reissued a “buy” rating and issued a GBX 330 ($4.35) target price on shares of ConvaTec Group PLC in a research report on Sunday, August 6th. One equities research analyst has rated the stock with a sell rating, six have issued a hold rating and four have issued a buy rating to the stock. ConvaTec Group PLC presently has an average rating of “Hold” and a consensus target price of GBX 266.70 ($3.52).

About ConvaTec Group PLC

ConvaTec Group Plc is a medical product and technology company. The Company focuses on therapies for the management of chronic conditions, including products used for advanced chronic and acute wound care, ostomy care, continence and critical care and infusion devices used in the treatment of diabetes and other conditions.

Receive News & Ratings for ConvaTec Group PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ConvaTec Group PLC and related companies with Analyst Ratings Network's FREE daily email newsletter.